Stroke |
Brain Attack; Carotid Endarterectomy; Cerebrovascular Disease |
Clinical Trial: Walking Therapy In Hemiparetic Stroke Patients Using Robotic-Assisted Treadmill Training
This study is currently recruiting patients.
|
Purpose
The overall goal of this study is to determine whether robotic-assisted gait training is better than standard physical therapy treatments for improving walking ability in hemiparetic stroke patients.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Hemiparesis Stroke | Device: Lokomat (Robotic Orthosis) combined with slat belt treadmill | Phase I |
MedlinePlus related topics: Neurologic Diseases; Stroke
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: Gait Restoration In Hemiparetic Stroke Patients Using Goal-Directed, Robotic-Assisted, Treadmill Training
Expected Total Enrollment: 50
Study start: November 2002
Subjects enrolled into the study will be randomly assigned to one of 2 groups. The first group will receive one hour of conventional gait training, consisting of lower extremity strengthening exercises, stretching, and full weight bearing walking as tolerated, with appropriate physical assistance from a therapist. The second group will receive walking therapy using a Lokomat, which is a special treadmill that works in conjunction with 2 light-weight robotic arms that assists the subject to move their legs while they try to walk on the treadmill. Some of the subject’s body-weight will be supported using a harness. During Lokomat training sessions, subjects will receive feedback of their walking performance on a computer monitor to help them walk. Both groups will be trained for 8-10 weeks, 3 times per week, for 1 hour training sessions (24 total sessions). Resources for transportation to the National Rehabilitation Hospital will be provided to all study participants.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion:
- Unilateral brain lesion.
- Within 6 months post-stroke.
- Receiving no other therapy targeting function of lower limb.
- Demonstration of hemiparesis (motor dysfunction in lower limb).
- Able to walk 5 meters without therapist assistance (walking device only).
- Able to follow commands and protocol.
Exclusion:
- Significant cognitive or communication impairments.
- Uncontrolled hypertension.
- Unontrolled diabetes.
- Clinical depression.
Location and Contact Information
District of Columbia
National Rehabilitation Hospital, Washington, District of Columbia, 20010, United States; Recruiting
Dr. Joseph M Hidler, Ph.D., Principal Investigator
Dr. Joseph M Hidler, Ph.D., Principal Investigator, The Catholic University of America
More Information
Website of research lab
Record last reviewed: January 2004
Last Updated: October 13, 2004
Record first received: January 8, 2004
ClinicalTrials.gov Identifier: NCT00075283
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- ''''The Free-Radical Theory of Aging: Part I - How it all began'''' (HealthWorld)
- Accidente Cerebrovascular: Esperanza en la Investigaciуn (National Institute of Neurological Diseases and Stroke)

Not Signed In -

